New research suggests that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain shed pounds much more quickly than those who stop traditional lifestyle programs.
Published data in a major health publication shows that while overweight people frequently drop about a fifth of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month after stopping.
"Individuals buying these treatments should be informed of the danger of quick weight regain when the therapy ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment mass in about 18 months.
Weighing Therapies
The research, which reviewed 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through lifestyle changes alone usually experience a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Rebound
Doctors believe the way of the injections accounts for the amplified regain.
The injections mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal may cause the system to produce less of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication results in hunger is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts argue that, due to the significant potential of relapse, the treatment should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who say that the results "highlight the persistent character of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Individuals who have discontinued the medication explain a intense return of hunger.
"I experienced a trigger activating and I was suddenly starving," recalled an individual.
This challenge is worsened if patients have not adopted sustainable lifestyle or habit changes during therapy.
Significant Interest
Survey data indicate that millions of adults in the UK have used these injections in the past year, with demand continuing to grow.
- Adoption is higher among females than men.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Ultimately, experts stress that while these medications are powerful agents for shedding pounds, they are not a magic cure and long-term success hinges on combined lifestyle support.
